Deep Longevity
Signal active
Organization
Contact Information
Overview
Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging using clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, imaging, and multiple other data types.
About
Industries
Biotechnology, Health Care
Founded
2020
Employees
1-10
Headquarters locations
Hong Kong, Hong Kong Island, Hong Kong, Asia
Social
Profile Resume
Deep Longevity headquartered in Asia, operates in the Biotechnology, Health Care sector. With a team of 1-10 employees, Deep Longevity is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Deep Longevity, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
7
Lead Investors
0
Total Funding Amount
$0
Details
1
Deep Longevity has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture |
Investors
Deep Longevity is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Formic Ventures | - | FUNDING ROUND - Formic Ventures | undefined |
| LongeVC | - | FUNDING ROUND - LongeVC | undefined |
| Deep Longevity | - | FUNDING ROUND - Deep Longevity | undefined |
| Emerging Technology Partners | - | FUNDING ROUND - Emerging Technology Partners | undefined |